医学
脑深部刺激
疾病
帕金森病
代谢组学
神经学
神经科学
药理学
刺激
血脑屏障
生物信息学
脑刺激
内科学
退行性疾病
发病机制
中枢神经系统
病理
中枢神经系统疾病
临床神经学
作者
Fabin Lin,Lebo Zhou,Lina Chen,Yufeng Xie,Yingqing Wang,Yuqi Zeng,Zhen Chen,Qinyong Ye,Woo‐Ping Ge,Guoen Cai
标识
DOI:10.1038/s41531-026-01487-5
摘要
Deep brain stimulation (DBS) constitutes one of the few therapeutic strategies for advanced Parkinson's disease. Although DBS causes rapid alterations in neuronal metabolism, whether it remodels the circulating metabolome and thereby alleviates systemic symptoms remains unknown. Here, we used high-performance liquid chromatography-mass spectrometry to perform untargeted plasma metabolomics of plasma samples from patients with Parkinson's disease pre- and post-DBS to profile transient metabolic alterations in plasma that could be attributed to DBS. Numerous metabolites involved in tyrosine metabolism-including dopamine, phenylacetaldehyde, 4-hydroxybenzaldehyde, and tyrosine-were reduced in abundance following DBS. In contrast, metabolites such as lactate were increased in abundance in response to DBS. We further characterized metabolites associated with the immediate therapeutic effects of DBS and identified acrylic acid level as a potential metabolic predictor of long-term prognosis. Collectively, our findings provide important insights into DBS-induced reprogramming of the plasma metabolome.
科研通智能强力驱动
Strongly Powered by AbleSci AI